AMLX Smart Money
Amylyx Pharmaceuticals, Inc.
1W: -0.9%
1M: -8.1%
3M: +38.6%
YTD: +137.2%
1Y: +89.3%
3Y: +63.7%
$28.30
+1.21 (+4.47%)
After Hours: $27.48 (-0.82, -2.92%)
Weekly Expected Move ±6.1%
$24
$26
$27
$29
$31
Credit Risk of going bust: lower than 78% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), Amylyx Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $5.3M against a stock market value of $3.40B.
Distance to default 9.13 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.6M (short-term plus half of long-term), stock volatility 75.9%; Altman Z'' 1.60. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down more than 99.9%), Amylyx Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $5.3M against a stock market value of $3.40B.
Distance to default 9.13 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.6M (short-term plus half of long-term), stock volatility 75.9%; Altman Z'' 1.60. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026223
Institutions Holding
+18 vs prior
61.0%
Ownership
+14.44%
54
New
70
Increased
73
Reduced
13
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | MILNE GEORGE M JR | director | S-Sale | 30,000 | $27.70 | $831K | Filing |
| 2026-09-10 | Mazzariello Gina | officer: chief legal officer | S-Sale | 11 | $33.34 | $367 | Filing |
| 2026-09-10 | Mazzariello Gina | officer: chief legal officer | S-Sale | 9,525 | $32.46 | $309K | Filing |
| 2026-09-10 | Cohen Joshua B | officer: co-chief executive officer | S-Sale | 919 | $33.15 | $30K | Filing |
| 2026-09-10 | Cohen Joshua B | officer: co-chief executive officer | S-Sale | 29,545 | $32.16 | $950K | Filing |
| 2026-09-10 | Klee Justin B. | officer: co-chief executive officer | S-Sale | 1,439 | $33.16 | $48K | Filing |
| 2026-09-10 | Klee Justin B. | officer: co-chief executive officer | S-Sale | 29,025 | $32.13 | $933K | Filing |
| 2026-09-10 | FRATES JAMES M | officer: chief financial officer | S-Sale | 1,042 | $33.23 | $35K | Filing |
| 2026-09-10 | FRATES JAMES M | officer: chief financial officer | S-Sale | 9,768 | $32.27 | $315K | Filing |
| 2026-09-10 | Bedrosian Camille L | officer: chief medical officer | S-Sale | 2,081 | $33.09 | $69K | Filing |
| 2026-09-10 | Bedrosian Camille L | officer: chief medical officer | S-Sale | 7,947 | $32.21 | $256K | Filing |
| 2026-08-18 | Cohen Joshua B | officer: co-chief executive officer | A-Grant/Award | 60,039 | $— | $0 | Filing |
| 2026-08-18 | Bedrosian Camille L | officer: chief medical officer | A-Grant/Award | 22,807 | $— | $0 | Filing |
| 2026-08-18 | Mazzariello Gina | officer: chief legal officer | A-Grant/Award | 21,284 | $— | $0 | Filing |
| 2026-08-18 | Klee Justin B. | officer: co-chief executive officer | A-Grant/Award | 60,039 | $— | $0 | Filing |
| 2026-08-18 | FRATES JAMES M | officer: chief financial officer | A-Grant/Award | 22,807 | $— | $0 | Filing |
| 2026-07-10 | Mazzariello Gina | officer: chief legal officer | S-Sale | 15,000 | $17.61 | $264K | Filing |
| 2026-07-09 | Mazzariello Gina | officer: chief legal officer | S-Sale | 15,000 | $18.32 | $275K | Filing |
| 2026-05-21 | Firestone Karen | director | P-Purchase | 3,800 | $13.51 | $51K | Filing |
| 2026-03-02 | Cohen Joshua B | officer: co-chief executive officer | S-Sale | 29,282 | $14.48 | $424K | Filing |
| 2026-03-02 | Bedrosian Camille L | officer: chief medical officer | S-Sale | 6,461 | $14.58 | $94K | Filing |
| 2026-03-02 | Mazzariello Gina | officer: chief legal officer | S-Sale | 6,844 | $14.52 | $99K | Filing |
| 2026-03-02 | Klee Justin B. | officer: co-chief executive officer | S-Sale | 29,282 | $14.47 | $424K | Filing |
| 2026-03-02 | FRATES JAMES M | officer: chief financial officer | S-Sale | 7,909 | $14.52 | $115K | Filing |
| 2026-02-23 | Mazzariello Gina | officer: chief legal officer | S-Sale | 3,419 | $14.14 | $48K | Filing |
🏛️ Congressional Trades
1 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2022-10-12 | Chris Jacobs | House | Buy | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 16,727,909 | $300M | +97,368 | 2026-06-30 | Filing |
| BlackRock, Inc. | 8,827,085 | $159M | -1,751 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 8,334,882 | $150M | +50,000 | 2026-06-30 | Filing |
| TCG Crossover Management, LLC | 6,243,812 | $112M | — | 2026-06-30 | Filing |
| Commodore Capital LP | 5,650,000 | $101M | — | 2026-06-30 | Filing |
| Jupiter Topco LLC | 5,236,102 | $94M | +5,236,102 | 2026-06-30 | Filing |
| Saturn V Capital Management LP | 4,624,101 | $83M | +274,216 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,224,224 | $76M | +82,649 | 2026-06-30 | Filing |
| MORGAN STANLEY | 3,130,808 | $56M | +955,261 | 2026-06-30 | Filing |
| Driehaus Capital Management LLC | 3,036,970 | $55M | +49,823 | 2026-06-30 | Filing |
| First Light Asset Management, LLC | 3,023,256 | $54M | -167,389 | 2026-06-30 | Filing |
| FRANKLIN RESOURCES INC | 2,950,225 | $53M | +688,656 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 2,858,239 | $51M | +232,248 | 2026-06-30 | Filing |
| STATE STREET CORP | 2,603,337 | $47M | +240,176 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,335,315 | $42M | +124,383 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 1,863,650 | $35M | +1,703,987 | 2026-06-30 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,900,000 | $34M | -1,660,764 | 2026-06-30 | Filing |
| Siren, L.L.C. | 1,480,586 | $27M | +250,586 | 2026-06-30 | Filing |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,327,536 | $24M | -186,422 | 2026-06-30 | Filing |
| 683 Capital Management, LLC | 1,279,512 | $23M | -250,488 | 2026-06-30 | Filing |